Antibody drug conjugates (ADCs) are currently one of the fastest growing directions in tumor treatment, and great progress has been made in the areas of breast cancer, other solid tumors (such as gastric cancer, colorectal cancer, lung cancer), and hematological malignancies. To help drive this research, a group of world-renowned oncologists have joined together to launch a Special Collection with Clinical Medicine Insights: Oncology entitled “A Novel Strategy for Treatment of Cancer: Antibody Drug Conjugates”.

Read More